SHG · Clinical Research Centre/Lung Cancer CDR (Pilot)
CR
Pilot environment — synthetic demographics; real de-identified pathology sample (n=62; +80 synthetic; total 142).
All patients
Patient Record · MRN SMC-180655

SYN-013

[SYN] Victor Fornax · 64y · Female · Chinese · BMI 24 · ECOG 2
SVMC - Sunway Velocity · Medical Oncology · Dr. Kavitha Sundaram
IVA (T4, N3, M1a)Stable
ALK fusion
Clinical storyline

[SYN] Victor Fornax, a 64-year-old Chinese female (never, ECOG 2), presented in 2024-04 with incidental finding on routine health screening cxr. Workup confirmed Adenocarcinoma (Stage IV, ALK fusion). The MDT recommended first-line alectinib. Current status: Stable.

HPE Results
Adenocarcinoma: Acinar, ALK rearranged
Clinical Stage
IVA (T4, N3, M1a)
Pathological Stage
IVA (T4, N3, M1a)
Adenocarcinoma Subtype
Acinar
CEA (ng/mL)
136.3
Tumor (CT/PET)
6.2 cm
PET SUV
18.78
NGS Results
ALK fusion positive (EML4-ALK)